PPT-October 2022 I Nasdaq: MDWD
Author : ruby | Published Date : 2024-01-03
Developing Breakthrough NonSurgical Therapies Improving Patient Lives 2 Cautionary Note Regarding ForwardLooking Statements MediWound cautions you that all statements
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "October 2022 I Nasdaq: MDWD" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
October 2022 I Nasdaq: MDWD: Transcript
Developing Breakthrough NonSurgical Therapies Improving Patient Lives 2 Cautionary Note Regarding ForwardLooking Statements MediWound cautions you that all statements other than statements of historical fact included in this press release that address activities events or developments that we expect believe or anticipate will or may occur in the future are forwardlooking statements Although we believe that we have a reasonable basis for the forwardlooking statements contained herein they are based on current expectations about future events affecting us and are subject to risks assumptions uncertainties and factors all of which are difficult to predict and many of which are beyond our control Actual results may differ materially from those expressed or implied by the forwardlooking statements in this press release These statements are often but are not always made through the use of words or phrases such as anticipates intends estimates plans expects continues believe guidance outlook target future potential goals and similar words or phrases or future or conditional verbs such as will would should could may or similar expressions Specifically this press release contains forwardlooking statements concerning the anticipated progress development study design expected data timing objectives anticipated timelines expectations and commercial potential of our products and product candidates Among the factors that may cause results to be materially different from those stated herein are the inherent uncertainties associated with the uncertain lengthy and expensive nature of the product development process the timing and conduct of our studies of our products and product candidates including the timing progress and results of current and future clinical studies and our research and development programs the approval of regulatory submission by the European Medicines Agency or by any other regulatory authority our ability to obtain marketing approval of our products and product candidates in the US or other markets the clinical utility potential advantages and timing or likelihood of regulatory filings and approvals of our products and products our expectations regarding future growth including our ability to develop new products risks related to our contracts with BARDA market acceptance of our products and product candidates our ability to maintain adequate protection of our intellectual property competition risks the need for additional financing the impact of government laws and regulations and the impact of the COVID19 pandemic For example we are unable to predict how the pandemic will affect the overall healthcare infrastructure including the ability to recruit patients the ability to conduct the studies in medical sites and the pace with which governmental agencies such as the FDA will review and approve regulatory submissions Additional governmentimposed quarantines and requirements to shelter at home or other incremental mitigation efforts also may impact our ability to source supplies for our operations or our ability or capacity to manufacture sell and support the use of our products and product candidates in the future These and other significant factors are discussed in greater detail in . NASDAQ GLIMPSE 4.1 1 Overview - ITCH real - time data feed product, NASDAQ GLIMPSE 4.1 is a point - to - point data feed connection that provides direct data feed customers with the current state NASDAQ ITCH to Trade Options 1.Overview NASDAQ ITCH to Trade Options (ITO) is a direct data feed product offered by The NASDAQ Option Marketwhich features the following data elements: Protocol Option .. Holding Companies . Structure. Nasdaq. Nordic Ltd. (100%). Nasdaq. Clearing AB. (100%). Nasdaq. . Tallinn AS . . (100. %). Nasdaq Helsinki . Ltd. (100%). Nasdaq Holding . Denmark . A/S. (100%). NASDAQ: PEBO PROFILEINVESTMENT RATIONALE CULTURESTRATEGY STRATEGICPRIORITIESRESULTS WORKING TOGETHER. SUCCESS. NASDAQ: PEBO NASDAQ: PEBO NASDAQ: PEBO NASDAQ: PEBO STRATEGICPRIORITIESRESULTS PROFILEINV www.hampdenway.barnet.sch.uk www.brookhillnursery.barnet.sch.uk www.st - margarets.barnet.sch.uk 020 8449 5466 Holiday provision Monday 2 5 th October 202 1 – Friday 29 th October 202 1 Monday 20 th Total Instructional DaysS1 84/S296Student/Teacher CalendarGrading Period EndsWksTeacher InserviceAug 9 2021September 1720216First Day of SchoolAug 102021November520216Labor DaySep 6 2021December 17202 wwwhampdenwaybarnetschukwwwbrookhillnurserybarnetschukwwwst-margaretsbarnetschuk020 8449 5466Holiday provisionMonday 25thOctober2021Friday 29thOctober 2021Monday 20thDecember 2021Friday24thDecember 20 September2021NasdaqInc2x0000x0000 x/Attxachexd /xBottxom x/BBoxx 4x395x01 3x217x25 6x131x04 4x549x9 /xSubtxype x/Fooxter x/Typxe /Pxaginxatioxn 00x/Attxachexd /xBottxom x/BBoxx 4x395x01 3x217x25 6x131 x0000x0000 x/Attxachexd /xBottxom x/BBoxx 4x947x3 23x592x 568x92 x356x34 x/Subxtypex /Foxoterx /Tyxpe /xPagixnatixon 0x/Attxachexd /xBottxom x/BBoxx 4x947x3 23x592x 568x92 x356x34 x/Subxtypex /Foxoter Quality and Disparities Report. This presentation contains notes. Select View, then Notes page to read them.. Report Background. AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) has provided an annual summary of the status of health and healthcare delivery in the United States since 2003. . Changes and Updates. Data Owner: Amanda Leopard. September 15, 2022. Oregon Department of Education. 1. Agenda. 2022-2023 Updates. General Reminders. Collection Dates. Additional Help & Contacts. initiatives . ACSDA General . Assembly. May 16-18, . Buenos . Aires . Post trade industry. trends and challenges. Drivers to change. Changing Business Model. Regulations . Standardization. Competition. 2. Today’s Presentation. Department of Elementary and Secondary Education. Russell Johnston, . Deputy Commissioner. Anne Marie Stronach, . LEA Operations Support, Commissioner’s Office . Executive Office of Health and Human Services/Department of Public Health. 1. Kenya General Elections 2022. 2. Angola General Elections 2022. 3. Readiness of the Kingdom of Lesotho to hold elections in October 2022. . 21 SEPTEMBER 2022. Table of Contents . Historical . Overview of Elections in Kenya.
Download Document
Here is the link to download the presentation.
"October 2022 I Nasdaq: MDWD"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents